Download presentation
Presentation is loading. Please wait.
Published byAnastasia Peters Modified over 9 years ago
1
The Swedish Life Sciences Trend Analysis 2014
2
About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com www.biotechgate.com The Scandinavian Life Sciences Database is a part of the global Biotechgate. Our Swedish partners include SwedenBIO, Stockholm-Uppsala Life Science, Business Region Göteborg, Invest in Skåne and Medicon Valley. www.scandinavianlifesciences.com www.scandinavianlifesciences.com Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.comwww.venturevaluation.com
3
Overview of the Swedish Life-science industry 2014 Statistics Total Biotech Companies446 Medtech companies363 Pharma companies45 Investor companies34 Public / Non-Profit Organizations / Medical Facilities140 Other Life sciences companies967 Percentage of Publicly Owned Companies8% Venture Financing (2013) USD 48m Venture Financing (2012) USD 127m Number of Technologies 96 Licensing Opportunities 104
4
Number of Employees
5
Company Ownership
6
Overview of the Swedish Biotechnology Industry 2013 Statistics2014 Statistics 489Total Biotech Companies446 147Biotech - Therapeutics130 208Biotech - R&D Services202 134Biotech - Other114 1 (2012)Number of IPOs2 (2013) 8%Percentage of Publicly Owned Companies8% USD 127m (2012) Venture Capital RaisedUSD 27m (2013) 97Licensing Opportunities104
7
Company Foundation Timeline
8
Key Activities of Biotechnology Companies
9
Biotech products - Breakdown by Indication
10
Biotech Pipeline – Three-year Trend
11
Venture Financing in Sweden 2009 to 2013: yearly data, 2014: data up to date (Jan - Jun)
12
Major Financing Rounds (H2 2013 – H1 2014) CompanySectorUSD M Wilson Therapeutics AB Biotech – Therapeutics & Diagnostics 40 InDex Pharmaceuticals Biotech – Therapeutics & Diagnostics 20 Pharmalink AB Biotech – Therapeutics & Diagnostics 15
13
About Biotechgate Biotechgate contains over 30’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for free or learn more about the different subscription options, please visit www.biotechgate.com. www.biotechgate.com
14
Terms of Use The “Swedish Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11+41 (43) 321 86 60 8004 Zurichinfo@venturevaluation.com Switzerlandwww.venturevaluation.com
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.